Benzinga's Top Downgrades

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Analysts at Credit Suisse downgraded BIND Therapeutics (NASDAQ: BIND) from Outperform to Neutral. The price target for BIND Therapeutics has been lowered from $20 to $10. BIND Therapeutics' shares closed at $6.72 yesterday.Analysts at BB&T Capital downgraded CIRCOR International (NYSE: CIR) from Buy to Hold and removed the price target of $85. CIRCOR International's shares closed at $64.79 yesterday. Analysts at BMO Capital downgraded Thor Industries (NYSE: THO) from Outperform to Market Perform. The price target for Thor Industries has been lowered from $62 to $54. Thor Industries' shares closed at $57.89 yesterday. Analysts at Leerink Swann downgraded Kindred Biosciences (NASDAQ: KIN) from Outperform to Market Perform. The price target for Kindred Biosciences has been lowered from $11.25 to $6. Kindred Biosciences' shares closed at $9.24 yesterday.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!